You just read:

AcelRx Initiates Phase 3 Study of Zalviso® in Patients with Moderate-to-Severe Acute Post-Operative Pain

News provided by

AcelRx Pharmaceuticals, Inc.

27 Sep, 2016, 07:00 ET